Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
Alistair Ring(National Health Service), Sunil R. Lakhani(Sullivan Nicolaides Pathology), Laura Fulford(Institute of Cancer Research), Ian E. Smith(Papworth Hospital), S. Ashley(Royal Marsden NHS Foundation Trust)
Cited by 262
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Mechanisms of tamoxifen resistance
|Endocrine Related Cancer|2004|652
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425